Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2001
10/10/2001EP1141299A2 Il-1 related polypeptides
10/10/2001EP1141298A2 Il-1 zeta, il-1 zeta splice variants and xrec2 dnas and polypeptides
10/10/2001EP1141297A2 Interleukin-17 related mammalian cytokines. polynucleotides encoding them . uses
10/10/2001EP1141296A2 Interferon-epsilon
10/10/2001EP1141294A1 Method of enhancing the biological activity of ligands
10/10/2001EP1141292A1 Monocyte-derived nucleic acids and related compositions and methods
10/10/2001EP1141290A2 Compositions and methods for therapy and diagnosis of ovarian cancer
10/10/2001EP1141288A2 Lymphocytic membrane proteins
10/10/2001EP1141287A1 Pancreatic polypeptide zsig66
10/10/2001EP1141286A1 Cytokine receptor chain
10/10/2001EP1141284A2 Methods and compositions for inhibiting neoplastic cell growth
10/10/2001EP1141280A1 Minor histocompatibility antigens and their use in the diagnosis and treatment of tumors
10/10/2001EP1141277A2 Antisense oligonucleotide for inhibiting the expression of the adhesion molecule very late antigen 4 (vla-4) in human cells
10/10/2001EP1141274A2 Soluble receptor br43x2 and methods of using them for therapy
10/10/2001EP1141270A1 Ethylene-response-factor1 (erf1) in plants
10/10/2001EP1141268A2 $i(A. FUMIGATUS) ACETYL COENZYME-A CARBOXYLASE GENES AND POLYPEPTIDES AND USES THEREOF
10/10/2001EP1141266A2 Expression vectors comprising multiple shear stress responsive elements (ssre) and a gene of interest and methods of use thereof
10/10/2001EP1141255A1 Modified forms of hepatitis c virus ns3 protease
10/10/2001EP1141254A1 Endo-beta-1,4-xylanase inhibitor from wheat flour and its effect on different xylanases
10/10/2001EP1141252A2 Human desaturase gene and uses thereof
10/10/2001EP1141250A2 Intein-mediated cyclization of peptides
10/10/2001EP1141249A1 Method for separating viral particles
10/10/2001EP1141248A2 A METHOD FOR THE HIGH LEVEL EXPRESSION OF ACTIVE LYMPHOTOXIN-$g(b) RECEPTOR IMMUNOGLOBULIN CHIMERIC PROTEINS AND THEIR PURIFICATION
10/10/2001EP1141247A2 An animal model for identifying a common stem/progenitor to liver cells and pancreatic cells
10/10/2001EP1141246A2 Non-myeloablative tolerogenic treatment
10/10/2001EP1141245A1 Somatic cells with ablated prp gene and methods of use
10/10/2001EP1141244A1 Cell lineage markers
10/10/2001EP1141243A2 Methods of immunosuppression
10/10/2001EP1141242A2 Oocyte activation by sperm components
10/10/2001EP1141241A2 Astrocytes, their preparation and uses thereof
10/10/2001EP1141240A1 Use of cd40 engagement to alter t cell receptor usage
10/10/2001EP1141239A1 Improved methods for insertion of nucleic acids into circular vectors
10/10/2001EP1141238A1 Production of proteins
10/10/2001EP1141237A1 Pth receptor and screening assay utilizing the same
10/10/2001EP1141028A2 Human monoclonal antibodies to ctla-4
10/10/2001EP1141026A1 Compositions and methods for generating monoclonal antibodies representative of a specific cell type
10/10/2001EP1141024A2 Polypeptide variants with altered effector function
10/10/2001EP1141022A1 Serine protease inhibitor
10/10/2001EP1141020A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
10/10/2001EP1141017A2 Characterization of the soc/crac calcium channel protein family
10/10/2001EP1141013A2 EXPRESSION AND EXPORT OF ANTI-OBESITY PROTEINS AS Fc FUSION PROTEINS
10/10/2001EP1141009A2 Reagents and methods useful for detecting diseases of the breast
10/10/2001EP1141007A1 Compositions and methods for enhancement of major histocompatibility complex class i restricted antigen presentation
10/10/2001EP1141003A1 Methods
10/10/2001EP1141001A2 Screening methods based on the use of protein kinases
10/10/2001EP1140999A1 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF
10/10/2001EP1140998A1 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF
10/10/2001EP1140997A2 Chlamydia trachomatis antigens
10/10/2001EP1140996A2 Type iii secretion system antigens from bordetella pertussis
10/10/2001EP1140994A1 Outer surface proteins, their genes, and their use
10/10/2001EP1140978A1 Methods of identifying antigen gene sequences
10/10/2001EP1140973A1 Protein-protein interactions in neurodegenerative disorders
10/10/2001EP1140971A1 Antisense modulation of novel anti-apoptotic bcl-2-related proteins
10/10/2001EP1140970A1 47 human secreted proteins
10/10/2001EP1140968A1 Dna molecules encoding splice variants of the human melanocortin 1 receptor protein
10/10/2001EP1140966A1 Acid stable backbone modified end-blocked nucleic acids and therapeutic uses thereof
10/10/2001EP1140938A2 High affinity inhibitors for target validation and uses thereof
10/10/2001EP1140928A2 Microbial transformation method for the preparation of an epothilone
10/10/2001EP1140240A1 Injectable hyaluronic acid derivative with pharmaceuticals/cells
10/10/2001EP1140207A1 Mammalian cell preparations optionally transfected with a gene coding for an active substance containing same
10/10/2001EP1140205A2 GENE THERAPY FOR PULMONARY EDEMA USING ADENOVIRUS VECTORS ENCODING Na,K-ATPase
10/10/2001EP1140175A2 Antibodies to truncated vegf-d and uses thereof
10/10/2001EP1140174A1 Agonists or antagonists of cutaneous t cell-attracting chemokine (ctack) or vasoactive intestinal contractor (vic) chemokines
10/10/2001EP1140171A1 Methods and products for regulating lectin complement pathway associated complement activation
10/10/2001EP1140154A2 Chorionic gonadotropin dna vaccines and methods
10/10/2001EP1140149A1 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
10/10/2001EP1140140A2 Composition and method for improving function of embryonic kidney transplants
10/10/2001EP1140120A2 Human brainiac-5
10/10/2001EP1140043A2 Transgenic plants comprising a conditionally lethal gene
10/10/2001EP1139915A1 Apparatus and method for sterilizing, seeding, culturing, storing, shipping and testing tissue, synthetic, or native vascular grafts
10/10/2001EP1093378A4 Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots
10/10/2001EP1012241A4 Screening assays for g protein coupled receptor agonists and antagonists
10/10/2001EP0804233B1 Methods for the cultivation of infectious laryngotracheitis virus and egg drop syndrome virus
10/10/2001EP0790767B1 Wound repair dressings and methods for their preservation
10/10/2001CN1317051A HMP-P rinase and TMP-PPase from arabidopsis thaliana and their use in herbicide screening
10/10/2001CN1317048A Nucleic acid molecules which code for enzymes with fructosyltransferase activity and use thereof
10/10/2001CN1317047A GBS toxin receptor
10/10/2001CN1317044A Nucleic acids encoding proteins involved in sensory transduction
10/10/2001CN1317015A Human anti-factor IX/IXa antibodies
10/10/2001CN1317010A Nucleic acids encoding G-protein coupled receptor involved in sensory
10/10/2001CN1316910A Composition and methods for regulating lymphocyte activation
10/10/2001CN1316878A Method of performing transgenesis
10/10/2001CN1316517A Leavo-dikotone reductase gene and its usage
10/10/2001CN1316432A Cell death inhibitory albumen
10/10/2001CN1072719C Isolated nucleic acid sequence coding for tumor rejection antigen precursor
10/10/2001CN1072717C Assay method for mammalian physiological cell
10/09/2001US6300540 Genetically engineered rodent model; for use in diagnosis an treatment of alzheimer's disease
10/09/2001US6300539 Model for chronic cerebral inflammation by intracerebral injection of double stranded RNA
10/09/2001US6300490 Expression vector coding cytosine deaminase; for use in the treatment of cancers
10/09/2001US6300484 DNA encoding DP. 75 and a process for its use
10/09/2001US6300474 Modified interferons
10/09/2001US6300472 Rab proteins
10/09/2001US6300311 Administering epidermal growth factor to pigs to increase litter size
10/09/2001US6300310 Amino acid sequence with segments of polypeptides
10/09/2001US6300130 Ultra rapid freezing for cell cryopreservation
10/09/2001US6300129 Transgenic non-human animals for producing heterologous antibodies
10/09/2001US6300128 Method for fixing cultured tissue and artificial skin fixed
10/09/2001US6300127 Bone mineralization proteins, DNA, vectors, expression systems
10/09/2001US6300119 Stretococcal ERS
10/09/2001US6300100 Process for preparing tissue factor pathway inhibitor